Results 71 to 80 of about 59,706 (153)
ABSTRACT Background To investigate the predictive value of aqueous humour cytokines for axial elongation. Methods This was a prospective longitudinal observational study. 72 high myopia patients (72 eyes) who received implantable collamer lens (ICL) implantation surgery with at least 2 years of follow‐up were included.
Lihui Meng +4 more
wiley +1 more source
Macular functional changes evaluated with MP-1 microperimetry after intravitreal bevacizumab for subfoveal myopic choroidal neovascularization: one year results [PDF]
Purpose: The purpose of this study was to evaluate 1-year functional and structural effects of intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to pathologic myopia (myopic choroidal neovascularization).
Falsini, Benedetto +4 more
core +1 more source
Axial length, myopia progression, and myopic maculopathy in Stickler syndrome
Abstract Purpose We lack knowledge on the potentially progressive nature of and the prevalence of complications to myopia as a characteristic trait of Stickler syndrome. Methods This cross‐sectional study combines ophthalmic examination and medical record data on Danish patients with genetically confirmed Stickler syndrome type 1 (COL2A1) and type 2 ...
Kirstine B. Boysen +4 more
wiley +1 more source
Choroidal neovascularization management in pathological myopia [PDF]
New approaches in the diagnosis and therapy of myopic Choroidal neovascularization (CNV). Long-tem effects of anti-VEGF therapy for subfoveal myopic CNV. Best treatment drug: Bevacizumab versus Ranibizumab. Effects of treatment regimen. Effects of myopic
PAPAYANNIS, Alessandro
core +1 more source
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld +5 more
wiley +1 more source
Choroidal neovascularization in patient undergoing growth hormone treatment
João R de Oliveira Dias1, Eduardo B Rodrigues2, Maurício Martinazzo2, Michel E Farah21Faculty of Medicine, University of Passo Fundo, Rio Grande do Sul, Brazil; 2Department of Ophthalmology, Federal University of São ...
João R de Oliveira Dias +3 more
doaj
Neovascular age‐related macular degeneration without drusen
Abstract Purpose To describe the clinical characteristics and 1‐year follow‐up of patients with neovascular AMD (nAMD) without drusen in either eye. Methods This is a multicentre retrospective cohort study in three tertiary referral centres in The Netherlands. We included patients of 55 years or older with nAMD in one or both eyes, without the presence
Marc J. Sirks +9 more
wiley +1 more source
Early neovascular bridging after photodynamic therapy of myopic choroidal neovascularization
Background: Photodynamic therapy is a relatively new modality for the treatment of subfoveal choroidal neovascularization (CNV). An unusual response to verteporfin therapy of myopic CNVs is reported.
LANZETTA, Paolo +4 more
core +1 more source
AIM: To evaluate the visual outcomes of choroidal neovascularization (CNV) secondary to pathological myopia and the impact of novel risk factors affecting the final visual outcome.
Tock-Han Lim +3 more
doaj +1 more source
Abstract Purpose The retinal pigment epithelium (RPE) is critical in the pathophysiology of retinal diseases, such as age‐related macular degeneration. Adaptive optics transscleral flood illumination (AO‐TFI) offers rapid, detailed morphometric characterization of the RPE layer.
Leila Sara Eppenberger +8 more
wiley +1 more source

